DIG - Overview: Digoxin, Serum
Monitoring digoxin therapy
DHTS - Overview: Dihydrotestosterone, Serum
Monitoring patients receiving 5-alpha reductase inhibitor therapy or chemotherapy Evaluating patients with possible 5-alpha reductase deficiency
EPO - Overview: Erythropoietin, Serum
An aid in distinguishing between primary and secondary polycythemia Differentiating between appropriate secondary polycythemia (eg, high-altitude living, pulmonary disease, tobacco use) and inappropriate secondary polycythemia (eg,...
ECULI - Overview: Eculizumab, Serum
Assessing the response to eculizumab therapy Assessing the need for dose escalation Evaluating the potential for dose de-escalation or discontinuation of therapy in remission states Monitoring patients who need to be above a certain...
HALO - Overview: Haloperidol, Serum
Optimizing haloperidol dosage Monitoring patient compliance Assessing toxicity
HAPT - Overview: Haptoglobin, Serum
Confirmation of intravascular hemolysis
FERR1 - Overview: Ferritin, Serum
Aiding in the diagnosis of iron deficiency and iron overload conditions Differentiating iron deficiency anemia and anemia of chronic disease
As part of the diagnosis and workup of precocious and delayed puberty in females and, to a lesser degree, males As part of the diagnosis and workup of suspected disorders of sex steroid metabolism (eg, aromatase deficiency and 17...
Investigation of suspected folate deficiency
ETX - Overview: Ethosuximide, Serum
Monitoring ethosuximide therapy Determining compliance Assessing ethosuximide toxicity
LGB3S - Overview: Globotriaosylsphingosine, Serum
Diagnosis and monitoring of Fabry disease
LID - Overview: Lidocaine, Serum
Assessing optimal lidocaine dosing during the acute management of ventricular arrhythmias following myocardial infarction or during cardiac manipulation such as surgery Assessing potential lidocaine toxicity
LIPA1 - Overview: Lipoprotein(a), Serum
Cardiovascular disease (CVD) risk refinement in patients with moderate or high risk based on conventional risk factors or patients with clinical suspicion of residual CV risk not identified by other lipid parameters
Investigating pancreatic disorders, usually pancreatitis
Aiding in the evaluation of iron deficiency and iron overload diseases in combination with total iron binding capacity and percent saturation Assessment of acute iron poisoning
ITCON - Overview: Itraconazole, Serum
Verifying systemic absorption of orally administered itraconazole Patients with life-threatening fungal infections Patients considered at risk for poor absorption or rapid clearance of itraconazole
Aiding in the diagnosis of multiple sclerosis and other central nervous system inflammatory conditions as a part of a profile
INS - Overview: Insulin, Serum
Diagnosing insulinoma, when used in conjunction with proinsulin and C-peptide measurements Management of diabetes mellitus
LITH - Overview: Lithium, Serum
Monitoring therapy of patients with bipolar disorders, including recurrent episodes of mania and depression Evaluating lithium toxicity
MEX - Overview: Mexiletine, Serum
Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity
MTHX - Overview: Methotrexate, Serum
Determining whether methotrexate is being cleared appropriately and verifying that a nontoxic concentration has been attained following therapy
MGS - Overview: Magnesium, Serum
Monitoring preeclampsia patients being treated with magnesium sulfate, although in most cases monitoring clinical signs (respiratory rate and deep tendon reflexes) is adequate and blood magnesium levels are not required
NOTRP - Overview: Nortriptyline, Serum
Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance
Confirmation of an elevated urinary nickel concentration This test is not useful for the investigation of nickel hypersensitivity.
UOSMS - Overview: Osmolality, Serum
Evaluating acutely ill or comatose patients
PBR - Overview: Phenobarbital, Serum
Monitoring for appropriate therapeutic concentration of phenobarbital Assessing compliance or toxicity
MYGLS - Overview: Myoglobin, Serum
Assessing muscle damage from any cause
MCRPL - Overview: Macroprolactin, Serum
Determining biologically active levels of prolactin, in asymptomatic patients with elevated prolactin levels Ruling out the presence of macroprolactin
SECOS - Overview: Secobarbital, Serum
Monitoring secobarbital therapy
SFZ - Overview: Sulfamethoxazole, Serum
Monitoring sulfamethoxazole therapy to ensure drug absorption, clearance, or compliance
Assessing acid-base balance, water balance, water intoxication, and dehydration
OSCAL - Overview: Osteocalcin, Serum
Monitoring and assessing effectiveness of antiresorptive therapy in patients treated for osteopenia, osteoporosis, Paget disease, or other disorders in which osteocalcin levels are elevated As an adjunct in the diagnosis of medical...
PRL - Overview: Prolactin, Serum
Aiding in evaluation of pituitary tumors, amenorrhea, galactorrhea, infertility, and hypogonadism Monitoring therapy of prolactin-producing tumors
PFN - Overview: Propafenone, Serum
Monitoring propafenone therapy Assessing potential propafenone toxicity
POSA - Overview: Posaconazole, Serum
Monitoring posaconazole therapy
PGSN - Overview: Progesterone, Serum
Ascertaining whether ovulation occurred in a menstrual cycle Assessment of infertility Evaluation of abnormal uterine bleeding Evaluation of placental health in high-risk pregnancy Determining the effectiveness of progesterone...
PENTS - Overview: Pentobarbital, Serum
Monitoring of pentobarbital therapy treatment
TRYPT - Overview: Tryptase, Serum
Evaluation of individuals with suspected mast cell activation, which may occur as a result of anaphylaxis or allergen challenge Evaluation of patients with suspected mast cell activation syndrome Evaluation of patients with suspected...
TRMP - Overview: Trimipramine, Serum
Monitoring trimipramine concentration during therapy Evaluating potential trimipramine toxicity May aid in evaluating patient compliance
TMP - Overview: Trimethoprim, Serum
Monitoring trimethoprim therapy to ensure drug absorption, clearance, or compliance
ZONI - Overview: Zonisamide, Serum
Monitoring zonisamide therapy; recommended for all patients to ensure appropriate dosing Assessing medication compliance
SVISC - Overview: Viscosity, Serum
Detection of increased viscosity Monitoring patients with hyperviscosity syndrome This test is not useful for patients with small concentrations of monoclonal proteins.
TIS - Overview: Titanium, Serum
Monitoring metallic prosthetic implant wear
THEO - Overview: Theophylline, Serum
Assessing and adjusting theophylline dosage for optimal therapeutic level Assessing theophylline toxicity
VORI - Overview: Voriconazole, Serum
Monitoring trough levels of voriconazole is suggested for: -Individuals with reduced liver function -Individuals with cytochrome P450 (CYP) 2C19 alterations associated with poor metabolic function -Patients taking other medications that...
ACMA - Overview: Acetaminophen, Serum
Monitoring toxicity in overdose cases
AMOBS - Overview: Amobarbital, Serum
Monitoring amobarbital therapy
KS - Overview: Potassium, Serum
Evaluation of electrolyte balance, cardiac arrhythmia, muscular weakness, hepatic encephalopathy, and renal failure
QUIN - Overview: Quinidine, Serum
Assessing and adjusting quinidine dosage for optimal therapeutic level Assessing quinidine toxicity
RAVU - Overview: Ravulizumab, Serum
Assessing the response to ravulizumab therapy Assessing the need for dose escalation Evaluating the potential for dose deescalation or discontinuation of therapy in remission states Monitoring patients who need to be above a certain...
sequential-maternal-serum-screening-testing-algorithm.pdf
Foundation for Medical Education and Research (MFMER). All rights reserved. Sequential Maternal Serum Screening Testing Algorithm Diagnostic testing should be offered Screen-positive: results reported...
MCL Platelet Antibody Screen Serum Information MC1235242
MCL Platelet Antibody Screen Serum Information Complete print Platelet Antibody Screen Serum Patient Information Reset Form Patient Information Patient Middle Birth Date...
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 26 - Insights
This week’s Research Roundup highlights the effect of inorganic nitrite versus a placebo on exercise capacity among patients with heart failure with preserved ejection fraction....
Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody...
Atypical Hemolytic Uremic Syndrome Complement Panel, Serum and Plasma
Detecting deficiencies in the alternative pathway that can cause atypical-hemolytic uremic syndrome, dense deposit disease, and C3 glomerulonephritis A second-tier test that aids in the differential diagnosis of thrombotic...